Latest filing published 09 Jul 2026 for Ironwood Pharmaceuticals INC, €505k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ronald Silver is a declared insider of Ironwood Pharmaceuticals Inc (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 20 July 2021 to 7 July 2026, the count stands at 22 filings.
Every open-market trade on record is a sale: 16 sales worth €964k. Outside the open market, there are 6 share grants. In 2026 alone, the filings show no purchases and 3 sales.
On 9 July 2026 came the latest disclosure, an open-market sale for €505k in Ironwood Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations